Mark Edward Mosteller - Net Worth and Insider Trading
Mark Edward Mosteller Net Worth
The estimated net worth of Mark Edward Mosteller is at least $8 dollars as of 2024-09-20. Mark Edward Mosteller is the Vice President, CFO of Oncternal Therapeutics Inc and owns about 5 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $8. Details can be seen in Mark Edward Mosteller's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Edward Mosteller has not made any transactions after 2013-07-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Edward Mosteller
Mark Edward Mosteller Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Edward Mosteller owns 1 companies in total, including Oncternal Therapeutics Inc (ONCT) .
Click here to see the complete history of Mark Edward Mosteller’s form 4 insider trades.
Insider Ownership Summary of Mark Edward Mosteller
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ONCT | Oncternal Therapeutics Inc | 2013-07-09 | Vice President & CFO |
Mark Edward Mosteller Latest Holdings Summary
Mark Edward Mosteller currently owns a total of 1 stock. Mark Edward Mosteller owns 5 shares of Oncternal Therapeutics Inc (ONCT) as of July 9, 2013, with a value of $8.
Latest Holdings of Mark Edward Mosteller
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ONCT | Oncternal Therapeutics Inc | 2013-07-09 | 5 | 1.59 | 8 |
Holding Weightings of Mark Edward Mosteller
Mark Edward Mosteller Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Edward Mosteller has made a total of 0 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years. The most-recent trade in Oncternal Therapeutics Inc is the sale of 12 shares on July 9, 2013, which brought Mark Edward Mosteller around $118,830.
Insider Trading History of Mark Edward Mosteller
- 1
Mark Edward Mosteller Trading Performance
GuruFocus tracks the stock performance after each of Mark Edward Mosteller's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Edward Mosteller is 3.46%. GuruFocus also compares Mark Edward Mosteller's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Edward Mosteller within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Edward Mosteller's insider trading performs compared to the benchmark.
Performance of Mark Edward Mosteller
Mark Edward Mosteller Ownership Network
Mark Edward Mosteller Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
Mark Edward Mosteller is the Vice President & CFO of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, Mark Edward Mosteller made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , a net purchase of 150,000 shares made by James B Breitmeyer , and a net purchase of 30,000 shares made by Richard G Vincent .
In summary, during the past 3 months, insiders sold 0 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 23,880 shares were bought by its insiders, resulting in a net purchase of 22,900 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
Mark Edward Mosteller Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Edward Mosteller. You might contact Mark Edward Mosteller via mailing address: 175 Toyota Plaza, 7th Floor, Memphis Tn 38103.